Mutations of the APC Gene in Human Sporadic Colorectal Cancers

Background: Mutations of the APC gene are reported to occur frequently in sporadic colorectal adenomas and adenocarcinomas. We studied APC gene mutations in cases of human sporadic colorectal cancer in order to evaluate their correlation with pathologic characteristics and clinical prognosis. Methods: Most of the mutations of the APC gene (95%) are nonsense or frame shift mutations, encoding for truncated APC proteins. For this reason, mutation detection of the APC gene was performed using the in vitro synthesized protein (IVSP) assay, analysing the region between nucleotide 2058 and nucleotide 5079 of the gene, containing the mutation cluster region. Results: Out of 58 cases of colorectal cancer, 29 presented a mutated form of APC (mutation frequency 50%). We did not find a statistically significant correlation between APC gene mutation and age, sex, localization of the primary tumour, grading, Crohn-like lymphoid reaction or presence of residual adenoma. Tumours with low invasivity (Dukes' stages A and B) were less frequently mutated (12/27, 44.5%) than tumours of Dukes' stage C (15 out of 21, 71.4%), which developed macroscopically secondary metastasis with variable latency after surgery. Highly invasive tumours with synchronous metastases (Dukes' stage D) had, instead, a low frequency of APC mutations (20%, 2/10) ( P = 0.02, compared with Dukes' stages A, B and C). Conclusions: These data suggest that more aggressive Dukes' stage D tumours develop metastasis by means of an unknown mechanism, independent of APC mutation.

[1]  Mariann Bienz,et al.  The APC tumour suppressor has a nuclear export function , 2000, Nature.

[2]  Thomas Kirchner,et al.  β-Catenin Regulates the Expression of the Matrix Metalloproteinase-7 in Human Colorectal Cancer , 1999 .

[3]  F. Al-Mulla,et al.  Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases , 1999, Genes, chromosomes & cancer.

[4]  H. McLeod,et al.  Tumour markers of prognosis in colorectal cancer , 1999, British Journal of Cancer.

[5]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[6]  J. Arends,et al.  APC mutations in human colorectal adenomas: analysis of the mutation cluster region with temperature gradient gel electrophoresis and clinicopathological features , 1998, The Journal of pathology.

[7]  Bert Vogelstein,et al.  Mutational Analysis of the APC/β-Catenin/Tcf Pathway in Colorectal Cancer , 1998 .

[8]  S. Gallinger,et al.  Molecular biology of colorectal cancer. , 1997, Current problems in cancer.

[9]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[10]  R. Deuter,et al.  DNA alterations in sporadic colorectal tumors do not correlate with tumor staging diagnosed by the TNM system. , 1996, Cancer letters.

[11]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[12]  Norifumi Ueda,et al.  Immunohistochemical detection of truncated APC protein in sporadic human colorectal adenomas and adenocarcinomas , 1996, Virchows Archiv.

[13]  Paul Polakis,et al.  Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly , 1996, Science.

[14]  K. Kinzler,et al.  Molecular determinants of dysplasia in colorectal lesions. , 1994, Cancer research.

[15]  V. Gismondi,et al.  Age of onset in familial adenomatous polyposis: heterogeneity within families and among APC mutations , 1994, Annals of human genetics.

[16]  T. Pollard,et al.  Wild-type but not mutant APC associates with the microtubule cytoskeleton. , 1994, Cancer research.

[17]  M. Fukayama,et al.  Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. , 1994, Cancer research.

[18]  K. Kinzler,et al.  Association of the APC tumor suppressor protein with catenins. , 1993, Science.

[19]  B. Vogelstein,et al.  Mutations of the APC (adenomatous polyposis coli) gene in FAP (familial polyposis coli) patients and in sporadic colorectal tumors. , 1992, The Tohoku journal of experimental medicine.

[20]  Bert Vogelstein,et al.  APC mutations occur early during colorectal tumorigenesis , 1992, Nature.

[21]  S. Altschul,et al.  Identification of FAP locus genes from chromosome 5q21. , 1991, Science.

[22]  Margaret Robertson,et al.  Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.

[23]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[24]  Nitin R. Patel,et al.  A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables , 1983 .

[25]  F. McCormick,et al.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. , 1999, Nature.

[26]  T. Brabletz,et al.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. , 1999, The American journal of pathology.

[27]  A. Sparks,et al.  Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. , 1998, Cancer research.

[28]  P. Polakis,et al.  Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. , 1996, Science.

[29]  Y. Nakamura,et al.  The role of the adenomatous polyposis coli (APC) gene in human cancers. , 1993, Advances in cancer research.

[30]  K. Kinzler,et al.  Molecular diagnosis of familial adenomatous polyposis. , 1993, The New England journal of medicine.

[31]  E. Hirst.  International Histological Classification of Tumours, No. 15, B.C. Morson, L.H. Sobin, in: Histological Typing of Intestinal Tumours. World Health Organization, Geneva (1976), 66, 134 colour plates. Sw. fr. 80, US$32.00. , 1978 .